Skip to main content
SpringerLink
Log in

Effects of alcoholic extract of Terminalia Chebula dried fruit on blood biochemical profile in diabetic rats

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Background

A considerable amount of attention has been recently paid to the discovery of effective natural antidiabetic drugs. Terminalia chebula is considered as the mother of herbs, with reported antidiabetic activity. This study aims to evaluate the renal and hepatic protective profile of its antidiabetic therapeutic doses.

Methods

To achieve the aim of the study, a total of 66 adult male rats of Sprague-Dawley species weighing about 180–200 g (weighed using a digital scale) were used. Type 2 diabetes mellitus (T2DM) was induced in using streptozotocin (STZ), rats were given a 5% dextrose solution for the next 24 h. Subjects received oral treatment of Terminalia chebula ethanolic extract at different doses (200, 400, and 600 mg/kg body weight) for 28 days. Measurements of fasting blood glucose level, change in body weight, lipid profile, serum liver enzymes, serum renal parameter, and histopathology of liver and kidney were carried out.

Results

Higher doses of Terminalia chebula (600 mg/Kg) were shown to have a potential therapeutic effect as well as the most prominent antidiabetic, antilipidemic activity, hepatoprotective and renoprotective profiles when compared to lower doses.

Conclusion

The use of Terminalia chebula alone or in combination with conventional antidiabetic drugs may be beneficial as a new advent therapy for diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. World Health Organization. Diabetes Fact sheet N°312" [Internet]. 2013 [cited 2014 Mar 25]. Available from: https://web.archive.org/web/20130826174444/http:/www.who.int/mediacentre/factsheets/fs312/en/

  2. www.diabetesatlas.org. IDF DIABETES ATLAS Ninth Edition [Internet] 2019 [cited 2020 May 18]. Available from: https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf

  3. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380.

  4. World Health Organization. Fact Sheet [Internet]. 2017 [cited 2019 Apr 10]. Available from: http://www.who.int/newsroom/ fact-sheet/detail/diabetes.

  5. Centers for Disease Control and Prevention. What is diabetes [Internet]. 2020. [cited 2021 Jul 18]. Available from: https://www.cdc.gov/diabetes/basics/diabetes.html

  6. World Health Organization. The top 10 causes of death [Internet]. 2020 [cited 2020 May 18]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

  7. World Health Organization. Global Health estimates 2013: deaths by cause, age, sex and country, 2000–2012, WHO, Geneva, Switzerland. 2014.

  8. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33.

  9. Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol 2013;4.

  10. Mahmoud AM, Ahmed OM, Ashour MB, Abdel-Moneim A. In vivo and in vitro antidiabetic effects of citrus flavonoids; a study on the mechanism of action. International Journal of Diabetes in Developing Countries 2015;35.

  11. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37.

  12. Gardner DG, MM, Shoback D, M, editors. Greenspan’s basic & clinical endocrinology. 9TH EDITION. New York: McGraw-Hill Medical; 2011.

  13. Kangralkar VA, Patil SD, Bandivadekar RM. Oxidative stress and diabetes: a review. Int J Pharm Appl. 2010;1(1):38–45.

    CAS  Google Scholar 

  14. Nabi SA, Kasetti RB, Sirasanagandla S, Tilak TK, Kumar MVJ, Rao CA. Antidiabetic and antihyperlipidemic activity of Piper longum root aqueous extract in STZ induced diabetic rats. BMC Complement Altern Med 2013;13.

  15. O. O. Oxidative stress in diabetes mellitus: is there a role for hypoglycemic drugs and/or antioxidants? Oxidative stress and diseases. InTech; 2012.

  16. Toma A. Recent advances on novel dual-acting peroxisome proliferator-activated receptor alpha and gamma agonists. Int J Pharm Sci Res. 2013;4:1644–53.

    CAS  Google Scholar 

  17. Cheng D, Liang B, Li Y. Antihyperglycemic effect of Ginkgo biloba extract in Streptozotocin-induced diabetes in rats. Biomed Res Int 2013;2013.

  18. Germplasm Resources Information Network (GRIN). Terminalia chebula Retz. Agricultural Research Service (ARS), United States Department of Agriculture (USDA). 2016.

  19. Kumar V, Choedon T. Medicinal plants used in the Practice of Tibetan medicine. 1st ed. GOVIL GN, editor. Studium Press, LLC, USA; 2013.

  20. Dr SS. Phytochemical and Pharmacognostic study on Haritaki (Terminalia chebula Retz.). IJRAR- International Journal of Research and Analytical Reviews. 2018;5:1500–5.

    Google Scholar 

  21. Chattopadhyay D, Naik T. Antivirals of Ethnomedicinal Origin: Structure-activity Relationship and Scope. Mini-Reviews in Medicinal Chemistry. 2007;7.

  22. Mahesh R, Bhuvana S, Hazeena Begum VM. Effect of Terminalia chebula aqueous extract on oxidative stress and antioxidant status in the liver and kidney of young and aged rats. Cell Biochem Funct 2009;27.

  23. Kannan VR, Rajasekar GS, Rajesh P, Balasubram V, Ramesh N, Solomon EK, et al. Anti-diabetic activity on Ethanolic extracts of fruits of Terminalia chebula Retz. Alloxan Induced Diabetic Rats American Journal of Drug Discovery and Development 2012;2.

  24. Akhand RN, Ahmed S, Bhowmik A, Rokeya B. Sub-chronic oral administration of the ethanolic extracts of dried Terminalia chebula mature fruits in streptozotocin (STZ)-induced type 2 diabetes mellitus (T2DM) model of long-Evans (L-E) rats improve glycemic, lipidemic and anti-oxidative status. J Appl Pharma Sci. 2013;3:027–32.

    Google Scholar 

  25. Borgohain R, Lahon K, Das S, Gohain K. Evaluation of mechanism of anti-diabetic activity of TERMINALIA CHEBULA on ALLOXAN and adrenaline induced diabetic albino rats. Intl J Pharma Bio Sci. 2012;3:256–66.

    Google Scholar 

  26. Lwin WW, Myint CYM, Maung M, Myint KTY. Formulation of capsule dosage form containing Ethanolic fruit extract of Terminalia chebula Retz. (Hpan-ga) having potent antioxidant activity. Myanmar Health Sci Res J. 2020;32:66–72.

    Google Scholar 

  27. Goodarzi MO, Bryer-Ash M. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes Obes Metab 2005;7.

  28. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical Management of Hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of diabetes. Diabetes Care 2009;32.

  29. Mst. khatun M, Md. Sapon A, Md. Hossain S, Md. Islam R. ANTIDIABETIC ACTIVITY OF PIPER BETLE IN ALLOXAN INDUCED TYPE 1 DIABETIC MODEL RATS. International journal of pharmaceutical sciences and research. 2016;7:675–80.

  30. Moree SS, Kavishankar GB, Rajesha J. Antidiabetic effect of secoisolariciresinol diglucoside in streptozotocin-induced diabetic rats. Phytomedicine. 2013;20.

  31. Liang B, Guo Z, Xie F, Zhao A. Antihyperglycemic and antihyperlipidemic activities of aqueous extract of Hericium erinaceus in experimental diabetic rats. BMC Complement Altern Med 2013;13.

  32. Ramachandran S, Rajasekaran A, Manisenthilkumar K. Investigation of hypoglycemic, hypolipidemic and antioxidant activities of aqueous extract of Terminalia paniculata bark in diabetic rats. Asian Pac J Trop Biomed 2012;2.

  33. Animal models of diabetic complications consortium protocols. High dose streptozotocin induction protocol (mouse). 2009;

  34. Emordi JE, Agbaje EO, Oreagba IA, Iribhogbe OI. Antidiabetic and hypolipidemic activities of hydroethanolic root extract of Uvaria chamae in streptozotocin induced diabetic albino rats. BMC Complement Altern Med 2016;16.

  35. Bancroft JD, Stevens A, Turner DR, editors. Theory and PRACTICE of histological techniques. Fourth Edition. New York , London , San Francisco , Tokyo.: Churchil Livingstone ; 1996.

  36. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–5.

    Article  CAS  Google Scholar 

  37. Finley PR, Tietz NW. Tietz clinical guide to laboratory tests, WB Saunders company. 4th ed: WB Saunders Company; 1996.

    Google Scholar 

  38. King J. The hydrolases-acid and alkaline phosphatases, in: practical clinical enzymology. (Ed.). London: Van D. Nostrand Co; 1965.

    Google Scholar 

  39. Gella FJ, Olivella T, Pastor MC, et al. A simple procedure for the routine determination of aspartate aminotransferase and alanine aminotransferase with pyridoxal phosphate. Clin Chim Acta. 1985;153:241–7.

    Article  CAS  Google Scholar 

  40. Fabiny DL, Ertingshausen G. Automated reaction-rate method for determination of serum creatinine with the CentrifiChem. Clin Chem. 1971;17:696–700.

    Article  CAS  Google Scholar 

  41. Tabacco A, Meiattini F, Moda E, Tarli P. Simplified Enzymic/colorimetric serum urea nitrogen determination. Clin Chem. 1979;25:336–7.

    Article  CAS  Google Scholar 

  42. Bolzán AD, Bianchi MS. Genotoxicity of Streptozotocin. Mutation research/reviews in Mutat Res 2002;512.

  43. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25.

  44. Kumar GPS, Arulselvan P, Kumar DS, Subramanian SP. Anti-diabetic activity of fruits of Terminalia chebula on Streptozotocin induced diabetic rats. J Health Sci 2006;52.

  45. Brenna Ø, Qvigstad G, Brenna E, Waldum HL. Cytotoxicity of Streptozotocin on neuroendocrine cells of the pancreas and the gut. Dig Dis Sci 2003;48.

  46. Abdelmeguid NE, Fakhoury R, Kamal SM, al Wafai RJ. Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats. Journal of Diabetes. 2010;2.

  47. Senthilkumar GP, Subramanian SP. Biochemical studies on the effect of Terminalia chebula on the levels of glycoproteins in streptozotocin-induced experimental diabetes in rats. J Appl Biomed 2008;6.

  48. Murali YK, Chandra R, Murthy PS. Antihyperglycemic effect of water extract of dry fruits ofTerminalia chebula in experimental diabetes mellitus. Indian J Clin Biochem 2004;19.

  49. Lee H-S, Koo Y-C, Suh HJ, Kim K-Y, Lee K-W. Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. J Ethnopharmacol 2010;131.

  50. Kazmi D, Rabbani DrI, Rehman DrH ur, Masood DrS. Effects of terminalia chebula on blood biochemical profile and pancreatic tissue in diabetic rats. Asian J Agri Bio 2014;2:235–44.

  51. Ewenighi C, Dimkpa U, Onyeanusi J, Onoh L, Onoh G, Ezeugwu U. Estimation of glucose level and body weight in Alloxan induced diabetic rat treated with aqueous extract of Garcinia Kola seed. The Ulutas Medical J 2015;1.

  52. Zafar M, Naeem-ul-Hassan Naqvi S. Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. Int J Morphol 2010;28.

  53. Goodman L, Gilman A. The pharmacological basis of therapeutics. 7th ed. New York: Macmillan; 1985.

    Google Scholar 

  54. Mitra SK, Gopumadhavan S, Muralidhar TS, Anturlikar SD, Sujatha MB. Effect of D-400, a herbomineral preparation on lipid profile, glycated haemoglobin and glucose tolerance in streptozotocin induced diabetes in rats. Indian J Exp Biol. 1995;33:798–800.

    CAS  PubMed  Google Scholar 

  55. Ravi K, Rajasekaran S, Subramanian S. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats. Food Chem Toxicol 2005;43.

  56. Yadav UCS, Moorthy K, Baquer NZ. Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats. Mol Cell Biochem 2005;268.

  57. Al-Attar AM. Physiological effects of some plant oils supplementation on Streptozotocin-induced diabetic rats. Res J Med Med Sci. 2010;5:55–70.

    CAS  Google Scholar 

  58. Rathore H, Soni S, Bhatnagar D. Hypocholesterolemic effect of Terminalia chebula fruit (Myrobalan) in mice. Anc Sci Life. 2004;23.

  59. Pederson BA, Schroeder JM, Parker GE, Smith MW, DePaoli-Roach AA, Roach PJ. Glucose metabolism in mice lacking muscle glycogen synthase. Diabetes. 2005;54.

  60. Juza RM, Pauli EM. Clinical and surgical anatomy of the liver: A review for clinicians. Clinical Anatomy. 2014;27.

  61. Elgazar AF, Rezq AA, Bukhari HM. Anti-hyperglycemic effect of saffron extract in Alloxan-induced diabetic rats. Eur J Biol Sci. 2013;5:14–22.

    Google Scholar 

  62. Menon N, Sparks J, Omoruyi F. Hypoglycemic and hypocholesterolemic activities of the aqueous preparation of Kalanchoe pinnata leaves in streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed 2015;5.

  63. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. US Renal Data System 2011 Annual Data Report. Am J Kidney Dis 2012;59.

  64. Thiruchelvi R, Arul D, Meenakshi S, Subramanian K. Protective effects of Terminalia Chebula fruit extract against cadmium-induced nephrotoxicity in rats. International J Environ Biol 2012;

  65. Negm SH, El-Soadaa SS. Effect of Terminalia chebula on cadmium-induced nephrotoxicity and lipid profiles in rats. Biosci Res. 2020;17:1535–44.

    Google Scholar 

  66. Muneer A, Alhowail A, Aldubayan M, Rabbani SI. The activity of Terminalia chebula Retz. Extract on doxorubicininduced renal damage in rats. J Pharm Pharmacog Res. 2020;8:237–46.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Damietta Oncology Centre, Damietta, Egypt

    Maha Eltimamy

  2. Department of Toxicology and Narcotics, Medical Division, National Research Centre, Damietta, Egypt

    Marwa Elshamarka

  3. Department of Clinical Pharmacy Practice, Faculty of Pharmacy, The British University in Egypt, El Shorouk City, Egypt

    Marina Aboelsaad & Moustafa Sayed

  4. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt

    Helmy Moawad

Authors
  1. Maha Eltimamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marwa Elshamarka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marina Aboelsaad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Moustafa Sayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Helmy Moawad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helmy Moawad.

Ethics declarations

Conflict of interest

The authors declared that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 335 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eltimamy, M., Elshamarka, M., Aboelsaad, M. et al. Effects of alcoholic extract of Terminalia Chebula dried fruit on blood biochemical profile in diabetic rats. J Diabetes Metab Disord 21, 159–170 (2022). https://doi.org/10.1007/s40200-021-00951-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-021-00951-8

Keywords

Search

Navigation